{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:58:17Z","timestamp":1790459897861,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T00:00:00Z","timestamp":1445904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"},{"start":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T00:00:00Z","timestamp":1445904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2015,11,3]]},"DOI":"10.1038\/bjc.2015.269","type":"journal-article","created":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T21:02:14Z","timestamp":1445979734000},"page":"1249-1253","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Upcoming translational challenges for uveal melanoma"],"prefix":"10.1038","volume":"113","author":[{"given":"Amirouchene-Angelozzi","family":"Nabil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Schoumacher","family":"Marie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stern","family":"Marc-Henri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassoux","family":"Nathalie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desjardins","family":"Laurence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piperno-Neumann","family":"Sophie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lantz","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman-Roman","family":"Sergio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,27]]},"reference":[{"key":"BFbjc2015269_CR1","first-page":"313","volume":"42","author":"Y Aalto","year":"2001","unstructured":"Aalto Y, Eriksson L, Seregard S, Larsson O, Knuutila S (2001) Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma. Invest Ophthalmol Vis Sci 42: 313\u2013317.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFbjc2015269_CR2","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/j.molonc.2014.06.004","volume":"8","author":"N Amirouchene-Angelozzi","year":"2014","unstructured":"Amirouchene-Angelozzi N, Nemati F, Gentien D, Nicolas A, Dumont A, Carita G, Camonis J, Desjardins L, Cassoux N, Piperno-Neumann S, Mariani P, Sastre X, Decaudin D, Roman-Roman S (2014) Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target. Mol Oncol 8: 1508\u20131520.","journal-title":"Mol Oncol"},{"key":"BFbjc2015269_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ajo.2009.01.023","volume":"148","author":"JJ Augsburger","year":"2009","unstructured":"Augsburger JJ, Corr\u00eaa ZM, Shaikh AH (2009) Effectiveness of treatments for metastatic uveal melanoma. Am J Ophthalmol 148: 119\u2013127.","journal-title":"Am J Ophthalmol"},{"key":"BFbjc2015269_CR4","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1002\/ijc.28436","volume":"134","author":"F-C Bidard","year":"2014","unstructured":"Bidard F-C, Madic J, Mariani P, Piperno-Neumann S, Rampanou A, Servois V, Cassoux N, Desjardins L, Milder M, Vaucher I, Pierga J-Y, Lebofsky R, Stern M-H, Lantz O (2014) Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma. Int J Cancer 134: 1207\u20131213.","journal-title":"Int J Cancer"},{"key":"BFbjc2015269_CR5","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.ajo.2014.07.014","volume":"158","author":"KF Bol","year":"2014","unstructured":"Bol KF, Mensink HW, Aarntzen EHJG, Schreibelt G, Keunen JEE, Coulie PG, de Klein A, Punt CJA, Paridaens D, Figdor CG, de Vries IJM (2014) Long overall survival after dendritic cell vaccination in metastatic uveal melanoma patients. Am J Ophthalmol 158: 939\u2013947.","journal-title":"Am J Ophthalmol"},{"key":"BFbjc2015269_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/eye.2012.253","volume":"27","author":"IHG Bronkhorst","year":"2013","unstructured":"Bronkhorst IHG, Jager MJ (2013) Inflammation in uveal melanoma. Eye 27: 217\u2013223.","journal-title":"Eye"},{"key":"BFbjc2015269_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc3459","volume":"13","author":"M Carbone","year":"2013","unstructured":"Carbone M, Yang H, Pass HI, Krausz T, Testa JR, Gaudino G (2013) BAP1 and cancer. Nat Rev Cancer 13: 153.","journal-title":"Nat Rev Cancer"},{"key":"BFbjc2015269_CR8","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1001\/jama.2014.6096","volume":"311","author":"RD Carvajal","year":"2014","unstructured":"Carvajal RD, Sosman JA, Quevedo JF, Milhem MM, Joshua AM, Kudchadkar RR, Linette GP, Gajewski TF, Lutzky J, Lawson DH, Lao CD, Flynn PJ, Albertini MR, Sato T, Lewis K, Doyle A, Ancell K, Panageas KS, Bluth M, Hedvat C, Erinjeri J, Ambrosini G, Marr B, Abramson DH, Dickson MA, Wolchok JD, Chapman PB, Schwartz GK (2014) Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial. JAMA 311: 2397\u20132405.","journal-title":"JAMA"},{"key":"BFbjc2015269_CR9","doi-asserted-by":"publisher","first-page":"4724","DOI":"10.1038\/onc.2013.418","volume":"33","author":"X Chen","year":"2014","unstructured":"Chen X, Wu Q, Tan L, Porter D, Jager MJ, Emery C, Bastian BC (2014) Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations. Oncogene 33: 4724\u20134734.","journal-title":"Oncogene"},{"key":"BFbjc2015269_CR10","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1158\/1078-0432.CCR-04-2054","volume":"11","author":"JP Ehlers","year":"2005","unstructured":"Ehlers JP, Harbour JW (2005) NBS1 expression as a prognostic marker in uveal melanoma. Clin Cancer Res 11: 1849\u20131853.","journal-title":"Clin Cancer Res"},{"key":"BFbjc2015269_CR11","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1158\/1078-0432.CCR-04-1941","volume":"11","author":"JP Ehlers","year":"2005","unstructured":"Ehlers JP, Worley L, Onken MD, Harbour JW (2005) DDEF1 is located in an amplified region of chromosome 8q and is overexpressed in uveal melanoma. Clin Cancer Res 11: 3609\u20133613.","journal-title":"Clin Cancer Res"},{"key":"BFbjc2015269_CR12","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1167\/iovs.03-1196","volume":"45","author":"C All-Ericsson","year":"2004","unstructured":"All-Ericsson C, Girnita L, M\u00fcller-Brunotte A, Brodin B, Seregard S, Ostman A, Larsson O (2004) c-Kit-dependent growth of uveal melanoma cells: a potential therapeutic target? Invest Ophthalmol Vis Sci 45: 2075\u20132082.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFbjc2015269_CR13","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ccr.2014.04.016","volume":"25","author":"X Feng","year":"2014","unstructured":"Feng X, Degese MS, Iglesias-Bartolome R, Vaque JP, Molinolo AA, Rodrigues M, Zaidi MR, Ksander BR, Merlino G, Sodhi A, Chen Q, Gutkind JS (2014) Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a Trio-regulated Rho GTPase signaling circuitry. Cancer Cell 25: 831\u2013845.","journal-title":"Cancer Cell"},{"key":"BFbjc2015269_CR14","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1158\/2159-8290.CD-13-0330","volume":"3","author":"SJ Furney","year":"2013","unstructured":"Furney SJ, Pedersen M, Gentien D, Dumont AG, Rapinat A, Desjardins L, Turajlic S, Piperno-Neumann S, de la Grange P, Roman-Roman S, Stern M-H, Marais R (2013) SF3B1 mutations are associated with alternative splicing in uveal melanoma. Cancer Discov 3: 1122\u20131129.","journal-title":"Cancer Discov"},{"key":"BFbjc2015269_CR15","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/leu.2014.28","volume":"28","author":"D Gentien","year":"2014","unstructured":"Gentien D, Kosmider O, Nguyen-Khac F, Albaud B, Rapinat A, Dumont AG, Damm F, Popova T, Marais R, Fontenay M, Roman-Roman S, Bernard OA, Stern M-H (2014) A common alternative splicing signature is associated with SF3B1 mutations in malignancies from different cell lineages. Leukemia 28: 1355\u20131357.","journal-title":"Leukemia"},{"key":"BFbjc2015269_CR16","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/978-1-62703-727-3_22","volume":"1102","author":"JW Harbour","year":"2014","unstructured":"Harbour JW (2014) A prognostic test to predict the risk of metastasis in uveal melanoma based on a 15-gene expression profile. Methods Mol Biol 1102: 427\u2013440.","journal-title":"Methods Mol Biol"},{"key":"BFbjc2015269_CR17","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1126\/science.1194472","volume":"330","author":"JW Harbour","year":"2010","unstructured":"Harbour JW, Onken MD, Roberson EDO, Duan S, Cao L, Worley LA, Council ML, Matatall KA, Helms C, Bowcock AM (2010) Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 330: 1410\u20131413.","journal-title":"Science"},{"key":"BFbjc2015269_CR18","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1158\/1078-0432.CCR-08-2243","volume":"15","author":"UB Hofmann","year":"2009","unstructured":"Hofmann UB, Kauczok-Vetter CS, Houben R, Becker JC (2009) Overexpression of the KIT\/SCF in uveal melanoma does not translate into clinical efficacy of imatinib mesylate. Clin Cancer Res 15: 324\u2013329.","journal-title":"Clin Cancer Res"},{"key":"BFbjc2015269_CR19","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.1158\/1078-0432.CCR-11-3227","volume":"18","author":"JS Khalili","year":"2012","unstructured":"Khalili JS, Yu X, Wang J, Hayes BC, Davies MA, Lizee G, Esmaeli B, Woodman SE (2012) Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner. Clin Cancer Res 18: 4345\u20134355.","journal-title":"Clin Cancer Res"},{"key":"BFbjc2015269_CR20","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1158\/1078-0432.CCR-11-0946","volume":"18","author":"S Landreville","year":"2012","unstructured":"Landreville S, Agapova OA, Matatall KA, Kneass ZT, Onken MD, Lee RS, Bowcock AM, Harbour JW (2012) Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma. Clin Cancer Res 18: 408\u2013416.","journal-title":"Clin Cancer Res"},{"key":"BFbjc2015269_CR21","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.molonc.2013.02.004","volume":"7","author":"C Laurent","year":"2013","unstructured":"Laurent C, Gentien D, Piperno-Neumann S, N\u00e9mati F, Nicolas A, Tesson B, Desjardins L, Mariani P, Rapinat A, Sastre-Garau X, Couturier J, Hup\u00e9 P, de Koning L, Dubois T, Roman-Roman S, Stern M-H, Barillot E, Harbour JW, Saule S, Decaudin D (2013) Patient-derived xenografts recapitulate molecular features of human uveal melanomas. Mol Oncol 7: 625\u2013636.","journal-title":"Mol Oncol"},{"key":"BFbjc2015269_CR22","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.18632\/oncotarget.2923","volume":"6","author":"Z Li","year":"2015","unstructured":"Li Z, Yu X, Shen J, Jiang Y (2015) MicroRNA dysregulation in uveal melanoma: a new player enters the game. Oncotarget 6: 4562\u20134568.","journal-title":"Oncotarget"},{"key":"BFbjc2015269_CR23","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1159\/000328333","volume":"49","author":"P Mariani","year":"2012","unstructured":"Mariani P, Servois V, Piperno-Neumann S (2012) Therapeutic options in metastatic uveal melanoma. Dev Ophthalmol 49: 166\u2013181.","journal-title":"Dev Ophthalmol"},{"key":"BFbjc2015269_CR24","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/ng.2674","volume":"45","author":"M Martin","year":"2013","unstructured":"Martin M, Ma\u00dfh\u00f6fer L, Temming P, Rahmann S, Metz C, Bornfeld N, van de Nes J, Klein-Hitpass L, Hinnebusch AG, Horsthemke B, Lohmann DR, Zeschnigk M (2013) Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3. Nat Genet 45: 933\u2013936.","journal-title":"Nat Genet"},{"key":"BFbjc2015269_CR25","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1158\/1535-7163.MCT-13-0550","volume":"13","author":"E Musi","year":"2014","unstructured":"Musi E, Ambrosini G, de Stanchina E, Schwartz GK (2014) The phosphoinositide 3-kinase \u03b1 selective inhibitor BYL719 enhances the effect of the protein kinase C inhibitor AEB071 in GNAQ\/GNA11-mutant uveal melanoma cells. Mol Cancer Ther 13: 1044\u20131053.","journal-title":"Mol Cancer Ther"},{"key":"BFbjc2015269_CR26","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1158\/1078-0432.CCR-09-3066","volume":"16","author":"F N\u00e9mati","year":"2010","unstructured":"N\u00e9mati F, Sastre-Garau X, Laurent C, Couturier J, Mariani P, Desjardins L, Piperno-Neumann S, Lantz O, Asselain B, Plancher C, Robert D, P\u00e9guillet I, Donnadieu M-H, Dahmani A, Bessard M-A, Gentien D, Reyes C, Saule S, Barillot E, Roman-Roman S, Decaudin D (2010) Establishment and characterization of a panel of human uveal melanoma xenografts derived from primary and\/or metastatic tumors. Clin Cancer Res 16: 2352\u20132362.","journal-title":"Clin Cancer Res"},{"key":"BFbjc2015269_CR27","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1158\/1078-0432.CCR-07-5144","volume":"14","author":"MD Onken","year":"2008","unstructured":"Onken MD, Worley LA, Harbour JW (2008) A metastasis modifier locus on human chromosome 8p in uveal melanoma identified by integrative genomic analysis. Clin Cancer Res 14: 3737\u20133745.","journal-title":"Clin Cancer Res"},{"key":"BFbjc2015269_CR28","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1158\/0008-5472.CAN-13-2269","volume":"74","author":"I P\u00e9guillet","year":"2014","unstructured":"P\u00e9guillet I, Milder M, Louis D, Vincent-Salomon A, Dorval T, Piperno-Neumann S, Scholl SM, Lantz O (2014) High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer. Cancer Res 74: 2204\u20132216.","journal-title":"Cancer Res"},{"key":"BFbjc2015269_CR29","first-page":"5s","volume":"32","author":"S Piperno-Neumann","year":"2014","unstructured":"Piperno-Neumann S, Kapiteijn E, Larkin JMG, Carvajal RD, Luke JJ, Seifert H, Roozen I, Zoubir M, Yang L, Choudhury S, Yerramilli-Rao P, Hodi FS, Schwartz GK (2014) Phase I dose-escalation study of the protein kinase C (PKC) inhibitor AEB071 in patients with metastatic uveal melanoma. J Clin Oncol 32: 5s.","journal-title":"J Clin Oncol"},{"key":"BFbjc2015269_CR30","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1093\/jnci\/82.22.1765","volume":"82","author":"G Prescher","year":"1990","unstructured":"Prescher G, Bornfeld N, Becher R (1990) Nonrandom chromosomal abnormalities in primary uveal melanoma. J Natl Cancer Inst 82: 1765\u20131769.","journal-title":"J Natl Cancer Inst"},{"key":"BFbjc2015269_CR31","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","volume":"363","author":"CD Van Raamsdonk","year":"2010","unstructured":"Van Raamsdonk CD, Griewank KG, Crosby MB, Garrido MC, Vemula S, Wiesner T, Obenauf AC, Wackernagel W, Green G, Bouvier N, Sozen MM, Baimukanova G, Roy R, Heguy A, Dolgalev I, Khanin R, Busam K, Speicher MR, O\u2019Brien J, Bastian BC (2010) Mutations in GNA11 in uveal melanoma. N Engl J Med 363: 2191\u20132199.","journal-title":"N Engl J Med"},{"key":"BFbjc2015269_CR32","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nature08966","volume":"465","author":"JC Scheuermann","year":"2010","unstructured":"Scheuermann JC, de Ayala Alonso AG, Oktaba K, Ly-Hartig N, McGinty RK, Fraterman S, Wilm M, Muir TW, M\u00fcller J (2010) Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB. Nature 465: 243\u2013247.","journal-title":"Nature"},{"key":"BFbjc2015269_CR33","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","volume":"118","author":"AD Singh","year":"2011","unstructured":"Singh AD, Turell ME, Topham AK (2011) Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology 118: 1881\u20131885.","journal-title":"Ophthalmology"},{"key":"BFbjc2015269_CR34","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1158\/1535-7163.MCT-13-0499","volume":"12","author":"O Surriga","year":"2013","unstructured":"Surriga O, Rajasekhar VK, Ambrosini G, Dogan Y, Huang R, Schwartz GK (2013) Crizotinib, a c-Met inhibitor, prevents metastasis in a metastatic uveal melanoma model. Mol Cancer Ther 12: 2817\u20132826.","journal-title":"Mol Cancer Ther"},{"key":"BFbjc2015269_CR35","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.molcel.2012.10.018","volume":"49","author":"JP Vaqu\u00e9","year":"2013","unstructured":"Vaqu\u00e9 JP, Dorsam RT, Feng X, Iglesias-Bartolome R, Forsthoefel DJ, Chen Q, Debant A, Seeger MA, Ksander BR, Teramoto H, Gutkind JS (2013) A genome-wide RNAi screen reveals a Trio-regulated Rho GTPase circuitry transducing mitogenic signals initiated by G protein-coupled receptors. Mol Cell 49: 94\u2013108.","journal-title":"Mol Cell"},{"key":"BFbjc2015269_CR36","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1136\/bjo.2008.144238","volume":"93","author":"PA Van der Velden","year":"2009","unstructured":"Van der Velden PA, Maat W (2009) Methylation in uveal melanoma. Br J Ophthalmol 93: 132.","journal-title":"Br J Ophthalmol"},{"key":"BFbjc2015269_CR37","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ccr.2014.04.017","volume":"25","author":"F-X Yu","year":"2014","unstructured":"Yu F-X, Luo J, Mo J-S, Liu G, Kim YC, Meng Z, Zhao L, Peyman G, Ouyang H, Jiang W, Zhao J, Chen X, Zhang L, Wang C-Y, Bastian BC, Zhang K, Guan K-L (2014a) Mutant Gq\/11 promote uveal melanoma tumorigenesis by activating YAP. Cancer Cell 25: 822\u2013830.","journal-title":"Cancer Cell"},{"key":"BFbjc2015269_CR38","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.1128\/MCB.00396-10","volume":"30","author":"H Yu","year":"2010","unstructured":"Yu H, Mashtalir N, Daou S, Hammond-Martel I, Ross J, Sui G, Hart GW, Rauscher FJ, Drobetsky E, Milot E, Shi Y, Affar EB (2010) The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression. Mol Cell Biol 30: 5071\u20135085.","journal-title":"Mol Cell Biol"},{"key":"BFbjc2015269_CR39","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1073\/pnas.1309085110","volume":"111","author":"H Yu","year":"2014","unstructured":"Yu H, Pak H, Hammond-Martel I, Ghram M, Rodrigue A, Daou S, Barbour H, Corbeil L, H\u00e9bert J, Drobetsky E, Masson JY, Di Noia JM, Affar EB (2014b) Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair. Proc Natl Acad Sci USA 111: 285\u2013290.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbjc2015269_CR40","doi-asserted-by":"publisher","first-page":"e0118564","DOI":"10.1371\/journal.pone.0118564","volume":"10","author":"L Zimmer","year":"2015","unstructured":"Zimmer L, Vaubel J, Mohr P, Hauschild A, Utikal J, Simon J, Garbe C, Herbst R, Enk A, K\u00e4mpgen E, Livingstone E, Bluhm L, Rompel R, Griewank KG, Fluck M, Schilling B, Schadendorf D (2015) Phase II DeCOG-study of ipilimumab in pretreated and treatment-na\u00efve patients with metastatic uveal melanoma. PLoS One 10: e0118564.","journal-title":"PLoS One"}],"updated-by":[{"DOI":"10.1038\/bjc.2015.456","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T00:00:00Z","timestamp":1450742400000}}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2015269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2015269","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2015269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:29:40Z","timestamp":1684416580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2015269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,27]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,11,3]]}},"alternative-id":["BFbjc2015269"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2015.269","relation":{"erratum":[{"id-type":"doi","id":"10.1038\/bjc.2015.456","asserted-by":"object"}]},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,27]]},"assertion":[{"value":"1 April 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}